Login / Signup

Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.

Elias KhajehArash Dooghaie MoghadamPegah EslamiSadeq Ali-Hasan-Al-SaeghAli RamouzSaeed ShafieiOmid GhamarnejadSepehr Abbasi DezfouliChristian RuppChristoph SpringfeldCarlos CarvalhoPascal ProbstSeyed Mostafa MousavizadehArianeb Mehrabi
Published in: BMC cancer (2022)
Statins increase the disease-free survival of patients with HCC after liver surgery. These drugs seem to have chemoprevention effects that decrease the probability of HCC recurrence after liver transplantation or liver resection.
Keyphrases
  • free survival
  • minimally invasive
  • coronary artery bypass
  • cardiovascular disease
  • surgical site infection
  • coronary artery disease
  • type diabetes
  • percutaneous coronary intervention